| pubmed-article:6487464 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6487464 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:6487464 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:6487464 | lifeskim:mentions | umls-concept:C0029297 | lld:lifeskim |
| pubmed-article:6487464 | lifeskim:mentions | umls-concept:C0033497 | lld:lifeskim |
| pubmed-article:6487464 | lifeskim:mentions | umls-concept:C1167622 | lld:lifeskim |
| pubmed-article:6487464 | lifeskim:mentions | umls-concept:C0599473 | lld:lifeskim |
| pubmed-article:6487464 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:6487464 | pubmed:dateCreated | 1984-12-18 | lld:pubmed |
| pubmed-article:6487464 | pubmed:abstractText | The binding of propranolol enantiomers to human albumin (ALB), alpha 1-acid glycoprotein (alpha 1-AGP) and plasma was studied. (-) propranolol is more bound than (+)propranolol to alpha 1-AGP (P less than 0.001) and to plasma (P less than 0.05). In solutions containing ALB at a constant concentration (580 mumol/l) and alpha 1-AGP at increasing concentrations, the binding of both isomers increases but the stereo selectivity is evident throughout the alpha 1-AGP concentration range examined (25-100 mumol/l). | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6487464 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6487464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6487464 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6487464 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:6487464 | pubmed:issn | 0306-5251 | lld:pubmed |
| pubmed-article:6487464 | pubmed:author | pubmed-author:RAOTs RTsR | lld:pubmed |
| pubmed-article:6487464 | pubmed:author | pubmed-author:BaruzziAA | lld:pubmed |
| pubmed-article:6487464 | pubmed:author | pubmed-author:AlbanoHH | lld:pubmed |
| pubmed-article:6487464 | pubmed:author | pubmed-author:ContinMM | lld:pubmed |
| pubmed-article:6487464 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6487464 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:6487464 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6487464 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6487464 | pubmed:pagination | 244-6 | lld:pubmed |
| pubmed-article:6487464 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:meshHeading | pubmed-meshheading:6487464-... | lld:pubmed |
| pubmed-article:6487464 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6487464 | pubmed:articleTitle | Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma. | lld:pubmed |
| pubmed-article:6487464 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6487464 | pubmed:publicationType | In Vitro | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6487464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6487464 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6487464 | lld:pubmed |
